Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Enforcement-nir
Subscribe today for access to
Articles and Reports
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.
OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
Cybersecurity Gets Presidential Attention
...
Already a member? Log in here
FDA Holds LDT Workshop Amid Flurry of Debate as Comment Period Nears End
...
Already a member? Log in here
FTC Gets Ready to Flex Enforcement Muscle Regarding Healthcare Integration
...
Already a member? Log in here
Ohio State Lab Settles CLIA PT Referral Case
...
Already a member? Log in here
Labs Face Multiple Medicare Threats in New Legislative Year
...
Already a member? Log in here
CMS Proposes Changes to CLIA Proficiency Testing Rules
...
Already a member? Log in here
OSHA Cites LabCorp for Safety Violations
...
Already a member? Log in here